Abstract
A well-defined series of 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine analogues was designed and synthesized in order to further ascertain the optimal structural requirements for S-adenosylmethionine decarboxylase inhibition and potentially to augment and perhaps separate their antiproliferative and antitrypanosomal activities. Most structural modifications had a deleterious affect on both the antitrypanosomal and antineoplastic activity of 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine. However, di-O-acetylation of the parent compound produced a potential prodrug that caused markedly pronounced inhibition of trypanosomal and neoplastic cell growth and viability. Moreover, the acetylated derivative of 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine did inhibit HIV-1 growth and infectivity, whereas the parent compound did not.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adenosylmethionine Decarboxylase / antagonists & inhibitors
-
Adenosylmethionine Decarboxylase / chemistry
-
Animals
-
Anti-HIV Agents / chemical synthesis*
-
Anti-HIV Agents / chemistry
-
Anti-HIV Agents / pharmacology
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology
-
Cell Line
-
Deoxyadenosines / chemical synthesis*
-
Deoxyadenosines / chemistry
-
Deoxyadenosines / pharmacology
-
Drug Screening Assays, Antitumor
-
HIV-1 / drug effects*
-
Humans
-
Male
-
Mice
-
Structure-Activity Relationship
-
Trypanocidal Agents / chemical synthesis*
-
Trypanocidal Agents / chemistry
-
Trypanocidal Agents / pharmacology
-
Trypanosoma brucei brucei / drug effects
-
Trypanosoma brucei rhodesiense / drug effects
-
Trypanosomiasis / drug therapy
-
Tumor Cells, Cultured
Substances
-
Anti-HIV Agents
-
Antineoplastic Agents
-
Deoxyadenosines
-
Trypanocidal Agents
-
MDL 73811
-
Adenosylmethionine Decarboxylase